Corkrean John J, Executive VP and CFO, has filed 94 Form 4 transactions across two companies, with the aggregate activity revealing a pronounced non-purchasing posture. Over the tracked period, his open-market purchases totaled $0, while open-market sales reached $857,764.38. The bulk of his reported activity, however, came from acquisitions valued at $7,241,479.53, nearly all of which were compensatory grants (code "A") rather than discretionary buys. This pattern—heavy awards, no open-market buying, and a modest but real sales total—suggests a manager accumulating equity through compensation structures while periodically liquidating shares.
The recent trades, all in H.B. Fuller Company (FUL) and Clearwater Paper (CLW), reinforce this trend. Between late January and late July 2026, Corkrean received a steady stream of FUL grants, typically valued around $12,603 each, arriving on a near-biweekly cadence. The largest single award was a $2,353,344.07 grant on January 26, 2026, accompanied by a $232,787.13 grant on January 30. He also exercised options (code "M") on January 26 and 27, valued at $84,338.28 and $86,186.21 respectively, with corresponding shares withheld for taxes (code "F") at $25,890.17 and $26,436.02. The only non-FUL activity was a $119,999.99 grant in CLW on May 8, 2026.
Notably, there are no recent open-market sales (code "S") in the latest filings, and the sell total appears concentrated in earlier periods. The absence of any "P" transactions across the entire history indicates Corkrean has not used personal capital to buy shares in either company during this window. Instead, his equity position has grown almost exclusively through scheduled compensation awards and option exercises, with the tax-withholding sales representing the only automatic disposals. The direction is clear: accumulation via corporate grants, not conviction buying, and no recent discretionary selling.
AI-assisted summary